儿童干预瘤学:我们现在在哪里?
Premal Amrishkumar Patel1,2, Fernando Gómez Muñoz3,4
1Interventional Radiology, Radiology Department, Great Ormond Street Hospital for Children, London, UK.
Journal of medical imaging and radiation oncology
|June 14, 2024
概括
儿科干预瘤学 (IO) 需要更具体的数据,因为成人方法对于特定的儿童癌症是不理想的. 本综述强调了IO在治疗儿科癌症中的当前用途和未来机会.
科学领域:
- 儿科瘤学 儿科瘤学
- 干预性放射学 干预性放射学
- 癌症研究 癌症研究
背景情况:
- 儿科干预瘤学 (IO) 的发展受到缺乏特定结果数据的阻碍.
- 依赖成年IO经验对于独特的儿科瘤类型,如神经母细胞瘤和肉瘤,是不理想的.
- 儿科干预放射学经常使用适应或非标签技术,影响结果.
研究的目的:
- 审查儿童癌症护理中干预性放射学的当前指示.
- 强调地方区域方法在儿科瘤学中的作用.
- 确定儿科IO的进展和未来的机会.
主要方法:
- 在儿童癌症中干预性瘤学应用的文献综述.
- 分析当前的指示,从活检到支持性护理.
- 探索疾病特异性的进展和挑战.
主要成果:
- 干预放射学 (IR) 在儿童癌症诊断,治疗和支持性护理方面发挥着作用.
- 地方区域的方法对于治疗儿科瘤至关重要.
- 在特定的儿科瘤疾病方面取得了进展,并确定了需要改进的领域.
结论:
- 对于儿童特异性数据的需求至关重要,以推进干预瘤学.
- 定制的干预技术和研究对于改善儿童癌症的结果至关重要.
- 对局部区域疗法的进一步研究有望为儿童癌症治疗提供希望.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


